Editorial commentary: Rabies postexposure vaccination: Are antibody responses adequate?

Clinical Infectious Diseases

Volumn 55, Issue 2, 2012, Pages 206-208

  Wilde, Henry ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE;

ANTIBODY RESPONSE; CD4 LYMPHOCYTE COUNT; DRUG TREATMENT FAILURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOGENICITY; NOTE; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; RABIES;

FEMALE; HUMANS; MALE; POST-EXPOSURE PROPHYLAXIS; RABIES;

EID: 84864144186     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis389     Document Type: Note

References (15)

1. World Health Organization. Rabies vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 85:309-20.
2. Suwansrinon K, Wilde H, Benjavongkulchai M, Banjongkasaena U, Lertjarutorn S, Boonchang S. Survival of neutralizing antibody in previously vaccinated subjects. Vaccine 2006; 24:3878-80.
3. Tantawichien T, Jaijaroensup W, Khawplod P, Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Clin Infect Dis 2001; 33:E122-4.
4. Martinetti M, De Silvestri A, Belloni C, et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000; 97:234-40.
5. Gross E, Belmaker I, Torok V. Diploid cell rabies vaccine, six or five. Lancet 1987; 12:1339. (Pubitemid 17156673)
6. Khawplod P, Wilde H, Sirikwin S, et al. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 2006; 24:3084-6.
7. Shantavasinkul P, Tantawichien T, Wilde H, et al. Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis 2010; 50:56-60.
8. Wilde H, Sirikawin S, Sabcharoen A, et al. Failure of postexposure treatment of rabies in children. Clin Infect Dis 1996; 22: 228-32. (Pubitemid 26056149)
9. Wilde H. Failure of post-exposure rabies prophylaxis. Vaccine 2007; 25:7605-9.
10. Centers for Disease Control and Prevention. Recovery of a patient from clinical rabies-California, 2011. Morb Mortal Wkly Rep 2012; 61:61-5.
11. Saraya A, Wacharapluesadee S, Khawplod P, et al. A preliminary study of chemo-and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens. Vaccine 2010; 28:4553-7.
12. Khawplod P, Wilde H, Benjavongkulchai M, Sriaroon C, Chomchey P. Immunogenicity study of abbreviated rabies preexposure vaccination schedules. J Travel Med 2007; 14: 173-6. (Pubitemid 46596284)
13. Sudarshan MK, Ravish HS, Ashwath Narayana DH. Time interval for booster vaccination following re-exposure to rabies in previously vaccinated subjects. Asian Biomed 2011; 5:589-94.
14. Lang J, Attanath P, Quiambao B, et al. Safety of equine rabies immune globulin. Lancet 1987; 2:1275.
15. Satpathy DM, Sahu T, Behera TR. Equine immunoglobulin: a study on its clinical safety. J Indian Med Assoc 2005; 103:241-2.